CIK 0001100682 · Large accelerated filer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sign in to watch- Ticker
- CRL
- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 27
- Entity type
- operating
- EIN
- 061397316
- Phone
- 781-222-6000
- Business address
- 251 BALLARDVALE ST, WILMINGTON, MA, 01887
- Former names
- CHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $2,974
- in 1 filing
- Open-market sales, last 90 days
- $20,291,281
- in 6 filings, $20.1M under 10b5-1 plans
Net −$20,288,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-29 | Barbo William D Corporate Executive VP & CCO | Shares withheld for taxes | −770 | $220.28 | $170K | 11,330 |
| 2024-01-29 | FOSTER JAMES C Chairman, President and CEO | Grant or award | +24,253 | 239,370 | ||
| 2024-01-29 | FOSTER JAMES C Chairman, President and CEO | Shares withheld for taxes | −10,757 | $220.28 | $2.4M | 228,613 |
| 2024-01-29 | FOSTER JAMES C Chairman, President and CEO | Option exercise | +17,436 | $144.67 | $2.5M | 227,827 |
| 2024-01-29 | FOSTER JAMES C Chairman, President and CEO | Shares withheld for taxes | −12,710 | $224.56 | $2.9M | 215,117 |
| 2024-01-29 | FOSTER JAMES C Chairman, President and CEO | Option exercise · Stock Options (Right to Buy) | −17,436 | 0 | ||
| 2024-01-10 | Girshick Birgit Corporate Executive VP & COO | Option exercise | +5,916 | $144.67 | $856K | 50,365 |
| 2024-01-10 | Girshick Birgit Corporate Executive VP & COO | Shares withheld for taxes | −4,617 | $213.14 | $984K | 45,748 |
| 2024-01-10 | Girshick Birgit Corporate Executive VP & COO | Option exercise · Stock Options (Right to Buy) | −5,916 | 0 | ||
| 2024-01-10 | Girshick Birgit Corporate Executive VP & COO | Option exercise | +5,916 | $215.19 | $1.3M | 50,365 |
| 2024-01-10 | Girshick Birgit Corporate Executive VP & COO | Shares withheld for taxes | −4,590 | $215.19 | $988K | 45,775 |
| 2024-01-10 | Girshick Birgit Corporate Executive VP & COO | Option exercise · Stock Options (Right to Buy) | −5,916 | 0 | ||
| 2023-12-14 | Creamer Victoria L EVP & Chief People Officer | Option exercise 10b5-1 | +3,381 | $144.67 | $489K | 19,887 |
| 2023-12-14 | Creamer Victoria L EVP & Chief People Officer | Option exercise 10b5-1 | +2,145 | $124.13 | $266K | 22,032 |
| 2023-12-14 | Creamer Victoria L EVP & Chief People Officer | Sale 10b5-1 | −5,526 | $225.00 | $1.2M | 16,506 |
| 2023-12-14 | Creamer Victoria L EVP & Chief People Officer | Option exercise · Stock Options (Right to Buy) 10b5-1 | −3,381 | 0 | ||
| 2023-12-14 | Creamer Victoria L EVP & Chief People Officer | Option exercise · Stock Options (Right to Buy) 10b5-1 | −2,145 | 0 | ||
| 2023-11-30 | LaPlume Joseph W EVP, Corp Strategy & Develop | Sale | −1,850 | $197.73 | $366K | 23,133 |
| 2023-11-20 | Girshick Birgit Corporate Executive VP & COO | Purchase | +1,322 | $187.82 | $248K | 44,449 |
| 2023-11-14 | FOSTER JAMES C Chairman, President and CEO | Purchase | +5,620 | $178.05 | $1.0M | 202,643 |
Page 19 of 41 · 819 trades